Pelthos Therapeutics Inc. (PTHS) Reports Q2 Loss of $5.38
Tweet
Share
E-mailGet Alerts PTHS Hot Sheet
Join SI Premium – FREE
Pelthos Therapeutics Inc. (NYSE: PTHS) reported Q2 EPS of ($5.38).
For earnings history and earnings-related data on Pelthos Therapeutics Inc. (PTHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
